Organization
Vectura Group Plc
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Vectura Group Plc
... Vectura Group plc (LSE: VEC) notifies that the Company's issued share capital as at 30 ...
... Vectura Group plc, an industry-leading inhaled product formulation, device design and development business, appointed ...
... 32.7p at 331.6p. Among the biggest fallers was FTSE 250 drug firm Vectura, where shares fell 11.05p to 87p as investors continued to digest news ...
... equity owned leader in medical diagnostics.Andrew will remain in his position at Vectura and on the Board until the end of July in order to ...
... of deals in the healthcare sector, a surge in embattled pharma firm Vectura's trading volume reignited longstanding bid rumours in the City as it soared ...
... Asthma inhaler maker Vectura said it is targeting better returns by doubling down on its lung ...
... Chippenham, UK - Vectura Group plc (LSE: VEC) ('Vectura' or the 'Group'), an industry-leading device and formulation business ...
... which will trigger a technology access fee of $1 million payable by Vectura to Pulmatrix in the second half of 2018.2018 YTD and 2017 ProgressPulmatrix ...
... copycat version of asthma drug Advair sent shares in struggling pharma firms Vectura and Hikma sliding back towards multiyear lows. The US Food and Drug ...
... full swing yesterday following the Christmas lull, speculating that asthma inhaler maker Vectura could be in the crosshairs of pharma giant GLAXOSMITHKLINE, looking to capitalise ...
Subscribe now for full coverage on Vectura Group Plc
Start My Free Trial